After Novo Nordisk projected yesterday that its revenue could decline by as much as 13% in 2026, its share price has plummeted by 20%. Because the Danish company attributed much of the shortfall to ...
The talks aim to lower costs for some of the most expensive treatments used by seniors; results of the first round of negotiations with drug makers went into effect this year. HealthDay News — Fifteen ...
The medications chosen for this negotiation cycle represent roughly $27 billion in total prescription drug spending under Medicare Part B and Part D. HealthDay News — Fifteen prescription medications, ...
The popular type 2 diabetes drug dulaglutide (Trulicity), botulinum toxin (Botox), and drugs to treat psoriatic arthritis, prostate cancer, and breast cancer are among the 15 drugs that the Centers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results